Clinical Trial Update: Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer

View source ↗

Summary

A clinical trial investigating tissue- and serum-derived exosomal microRNAs as predictors of response to neoadjuvant chemotherapy in breast cancer; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Breast Carcinoma

Snippet

Sponsor: Atlas University | Conditions: Breast Cancer, Invasive Breast Carcinoma | Status: NOT_YET_RECRUITING